Format

Send to

Choose Destination
Am J Prev Med. 2011 Nov;41(5):494-7. doi: 10.1016/j.amepre.2011.07.014.

Sexual violence victimization against men with disabilities.

Author information

1
Center for Health Policy and Research, Department of Family Medicine and Community Health, University of Massachusetts Medical School, Shrewsbury, 01545, USA. monika.mitra@umassmed.edu

Abstract

BACKGROUND:

Prior research has shown a high prevalence of sexual violence against women with disabilities. However, no previous population-based studies have examined such victimization against men with disabilities.

PURPOSE:

The purpose of this paper is to document the prevalence of lifetime and past-year sexual violence victimization among a representative sample of men with disabilities in Massachusetts and to compare its prevalence among men with disabilities to that of men without disabilities and women with and without disabilities.

METHODS:

Data from the Massachusetts Behavioral Risk Factor Surveillance System, 2005-2009 were analyzed in 2010 using bivariate and multivariate logistic regression.

RESULTS:

Among 25,756 survey respondents, approximately 21.1% of Massachusetts men and 21.0% of women reported a disability. The prevalence of lifetime sexual violence victimization was 13.9% (95% CI=10.7%, 17.1%) among men with disabilities; 3.7% (95% CI=2.9%, 4.5%) among men without disabilities; 26.6% (95% CI=23.4%, 29.7%) among women with disabilities; and 12.4% (95% CI=11.2%, 13.6%) among women without disabilities. Similarly, men with disabilities were more likely than men without disabilities to report lifetime completed and attempted rape and past-year sexual violence victimization. Multivariate analyses controlling for sociodemographic characteristics indicated that men with disabilities were more than four times more likely to report lifetime and past-year victimization than men without disabilities.

CONCLUSIONS:

Men with disabilities are at a heightened risk for lifetime and current sexual violence victimization.

PMID:
22011420
DOI:
10.1016/j.amepre.2011.07.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center